Kamedis

What Kamedis does

Kamedis is a privately held botanical skincare company headquartered in Tel Aviv, Israel, with a US subsidiary (Kamedis Inc.) operating from New York. The company develops and sells FDA-registered over-the-counter skincare products for eczema, dandruff, psoriasis, acne, and foot care, combining Traditional Chinese Medicine-derived botanical extracts with modern dermatological science. Its proprietary technology platform, Botaniplex, includes patented CALM Botaniplex (for eczema) and CLEAR Botaniplex (for acne) formulations, alongside the KAM-3008 barrier-based cream for atopic dermatitis. Clinical efficacy is documented in peer-reviewed publications in the Journal of Drugs in Dermatology and J Dermatolog Treat, with reported outcomes including 57.3% SCORAD improvement, 38.6% EASI improvement within two weeks, and up to 100% visible dandruff removal.

Kamedis generates revenue through direct-to-consumer e-commerce on a Shopify storefront (kamedis-usa.com), Amazon marketplace listings, and an authorized reseller network governed by a Minimum Advertised Price (MAP) policy. Unit prices range from $6.95 for accessories to $45.45 for a 3-month Ultimate Anti-Dandruff Kit supply, with bundle pricing offering roughly 20% discounts. The company has accumulated over 100,000 customers and receives earned media coverage in outlets including InStyle, Today.com, Oprah Magazine, Allure, and HuffPost, supported by endorsements from dermatologists such as Dr. Joshua Zeichner (Mount Sinai) and former American Association of Naturopathic Physicians president Dr. Michael Traub. No external funding rounds, headcount data, or revenue figures are publicly disclosed.

The business operates with a small organizational footprint (Tel Aviv HQ plus a US subsidiary) and a horizontal segmentation across multiple skin conditions. Distribution is anchored in the United States, with international orders potentially rejected per the Terms of Service. Approximately 90% of products are vegan and certified by the Vegan-Friendly Association, and the full range is marketed as steroid-free, paraben-free, SLS-free, and cruelty-free, targeting consumers seeking botanical alternatives to conventional dermatological treatments.

Name

Kamedis

Legal name

Kamedis Ltd.

Website

https://kamedis-usa.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

11–50 employees

Short description

Kamedis is a privately held Israeli-founded botanical skincare company selling FDA-registered OTC products for eczema, dandruff, acne, and psoriasis through its US e-commerce site, Amazon, and authorized resellers.

Ownership category

akta.pro rank

Product category

OTC Dermatological Skincare

NAICS

Cosmetics, Beauty Supplies, and Perfume Retailers (456120), Soap and Cleaning Compound Manufacturing (32561), Health and Personal Care Retailers (4561)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal) (CRADAMAF)

akta.pro secondary industries

Dermocosmetics & Medical-Grade Skincare (CRABAAAF), Dermatology & Topical Skin Treatments (HLAIADAE), Sensitive Skin & Barrier Repair (CRABAAAG)

Keywords

• Botanical skincare
• Eczema treatment
• Dandruff shampoo
• Acne treatment
• OTC dermatology

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Marketing or Sales

Revenue model

1. Direct E-commerce Sales: Direct-to-consumer sales through company's own online storefront at kamedis-usa.com, selling OTC botanical skincare products for eczema, dandruff, psoriasis, and acne conditions.
2. Marketplace Sales: Sales through Amazon marketplace where products are listed and sold directly to consumers.
3. Wholesale/Reseller Distribution: Products sold to authorized resellers and wholesalers who then sell to end consumers. Company maintains Minimum Advertised Price (MAP) policy for resellers.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Kamedis develops, manufactures and sells clinically proven OTC botanical skincare products that combine Traditional Chinese Medicine ingredients with modern dermatological science. Its product portfolio targets specific chronic skin conditions, including eczema/atopic dermatitis, dandruff/seborrheic dermatitis, psoriasis, and acne, anchored by proprietary Botaniplex formulation platforms (CALM Botaniplex, CLEAR Botaniplex, KAM-3008). Products are sold direct-to-consumer primarily through the company's own Shopify storefront (kamedis-usa.com) and Amazon, supplemented by authorized reseller distribution in the US and Israel.

Product overview

Kamedis offers a line of clinically proven botanical skincare products for specific skin conditions. The portfolio centers on three core collections: (1) Eczema/Atopic Dermatitis Treatment (CALM collection) featuring Eczema Therapy Cream and Face & Body Cream with CALM Botaniplex, (2) Dandruff/Scalp Control collection with Dandruff Therapy Shampoo, Scalp Lotion, and bundled kits including the Ultimate Anti-Dandruff Kit, and (3) Acne Treatment line featuring Acne Spot Treatment with CLEAR Botaniplex. Additional products include Instant Relief Gel, Nourishing Conditioner, and Hydrating Foot Gel. All products are formulated with high-concentration botanical extracts derived from Traditional Chinese Medicine, clinically tested and dermatologist-recommended, with key differentiator being proprietary Botaniplex blend technology combining multiple synergistic botanicals. The company positions itself as steroid-free, paraben-free, SLS-free, and cruelty-free.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• 57.3% improvement in SCORAD (Scoring Atopic Dermatitis)
• +6 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• AmazoncoreChannel Partner/ Reseller/ DistributorAmazon serves as a primary third-party marketplace distribution channel for Kamedis products. Products are listed and sold through Amazon including the Dandruff Therapy Shampoo, Scalp Lotion, and Eczema Therapy Cream. This marketplace presence expands reach beyond the company's own e-commerce site.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Direct peers

• La Roche-Posay: L'Oreal-owned dermo-cosmetic brand with strong position in sensitive skin, eczema, and acne. Clinically-positioned competitor with extensive dermatologist endorsement network and global pharmacy distribution.
• Eucerin: Beiersdorf-owned medical skincare brand with strong eczema, dry skin, and sensitive skin franchises. Competes in the same dermatologist-recommended OTC space with broader international presence.
• Cetaphil: Galderma-owned sensitive skin and eczema brand with deep dermatologist recommendations. Direct competitor in the gentle/steroid-free skincare positioning with extensive global distribution.
• Vanicream: Pharmaceutical Specialties brand focused on free-of sensitizers skincare for eczema, psoriasis, and sensitive skin. Direct niche competitor with strong dermatologist recommendations and similar OTC positioning.
• Cerave: L'Oreal-owned dermatologist-developed skincare brand focused on ceramides and barrier repair. Direct competitor in eczema/atopic dermatitis and sensitive skin categories, with massive retail distribution and far larger marketing budget.
• Aveeno: Johnson & Johnson skincare brand built on natural/colloidal oatmeal and botanical ingredients. Direct competitor in eczema and sensitive skin categories with major mass-market retail presence.
• Sarna: Prestige Consumer Healthcare anti-itch and eczema topical brand. Direct OTC competitor in the itch-relief and sensitive-skin category with established retail distribution.
• Mustela: Laboratoires Expanscience brand specializing in baby and sensitive skin care with botanical formulations. Direct competitor in the family-safe, botanical-positioned skincare space.
• Aquaphor: Beiersdorf healing ointment brand widely recommended by dermatologists for eczema and barrier repair. Competitor in the OTC eczema/healing category with major retail presence.

Emerging players

• The Ordinary: DECIEM/Estee Lauder clinical-skincare brand built on ingredient-led positioning and accessible pricing. Comparable in clinical-credibility marketing and online-first DTC distribution model, though focuses on serums rather than condition-specific OTC.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCEgUrnff9EGL7rvPhLM9Ulw
• Facebookfacebook.com/kamedisdermatology
• Instagraminstagram.com/kamedis_skin_care
• Xx.com/kamedisusa
• LinkedInlinkedin.com/company/kamedis

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kamedis